TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.

M Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.